NCT06098482 An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App
| NCT ID | NCT06098482 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cochlear |
| Condition | Hearing Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2024-02-05 |
| Primary Completion | 2027-05-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2024-02-05 with a primary completion date of 2027-05-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is a feasibility, prospective, repeated-measures, multi-country, multi-centre, study of the Mobile Research App to measure and validate speech perception endpoints in adult cochlear implant recipients.
Eligibility Criteria
Inclusion Criteria: * Adults 18 years of age or older. * Uses a hearing device or devices (hearing aid/s and/or cochlear implant/s). * Fluent speaker in the language used to assess clinical performance as judged by the investigator. * Willing and able to provide written informed consent. Exclusion Criteria: * Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator. * Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling. * Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation. * Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation). * Women who are pregnant.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06098482 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06098482 currently recruiting?
Yes, NCT06098482 is actively recruiting participants. Contact the research team at gdeceulaer@cochlear.com for enrollment information.
Where is the NCT06098482 trial being conducted?
This trial is being conducted at Lone Tree, United States, Melbourne, Australia, Antwerp, Belgium, Wommelgem, Belgium.
Who is sponsoring the NCT06098482 clinical trial?
NCT06098482 is sponsored by Cochlear. The trial plans to enroll 46 participants.